Clinical Trials
45 trialsReFOCUS1
University of Rochester
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
University of Iowa
High Dose Ascorbic Acid for Plasma Cell Disorders
University of Iowa
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
University of Iowa
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Thomas Jefferson University
Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Thomas Jefferson University
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
University of Iowa
Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
Bruckner Oncology
Pharmacological Ascorbate for Lung Cancer
University of Iowa
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
University of Iowa
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies
Weill Medical College of Cornell University
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
Region Skane
Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients
Virginia Commonwealth University
Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients
Oncotherapeutics
InsITE
University of Colorado, Denver
Vitality
Sun Yat-sen University
AA NABPLAGEM
HonorHealth Research Institute
Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia
Norgine
VICAST
Maastricht University Medical Center
A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma
Vanderbilt-Ingram Cancer Center
Topical Vitamin C for Treatment of Basal Cell Cancer
Center for Biomedical Research, Inc.
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
Case Comprehensive Cancer Center
Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients
M.D. Anderson Cancer Center
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
Case Comprehensive Cancer Center
Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
VCONSCLC
Clifford Hospital, Guangzhou, China
EVITA-Pilot
Rigshospitalet, Denmark
Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
University of Kansas Medical Center
New Treatment Option for Pancreatic Cancer
University of Kansas Medical Center
PHS II
Brigham and Women's Hospital
Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
Seoul National University Hospital
OM
Medical University of South Carolina
Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma
University of Miami
The Effect of Green Tea and Vitamin C on Skin Health
University of Manchester
Safety of Antioxidants During GYN Cancer Care
University of Kansas Medical Center
Evaluation of Intravenous Ascorbic Acid
University of Kansas Medical Center
Vitamin C as an Anti-cancer Drug
Copenhagen University Hospital at Herlev
VITAMIN E, C and ZINC IN PATIENTS WITH SKIN CANCER: INFLUENCE ON OXIDATIVE STRESS AND INFLAMMATORY STATE
University of Campinas, Brazil
Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
National Cancer Institute (NCI)
Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective
Jewish General Hospital
Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Washington University School of Medicine
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Barbara Ann Karmanos Cancer Institute
Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors
Midwestern Regional Medical Center
Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients
M.D. Anderson Cancer Center
Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.
Institut National de la Santé Et de la Recherche Médicale, France